Literature DB >> 6245245

Genome organization of retroviruses. V. In vitro-synthesized Moloney murine leukemia viral DNA has long terminal redundancy.

R A Bosselman, I M Verma.   

Abstract

Purified virions of Moloney murine leukemia virus can synthesize genome-length double-stranded DNA in vitro. Two predominant species of long DNA transcripts, with average sizes of 9.1 and 8.5 kilobases (kb) can be identified. Both species of DNA contain the negative (complementary to viral RNA) and positive (same polarity as viral RNA) strands. However, only the negative strand of the 8.5-kb species can be identified if the synthesis of DNA is carried out in the presence of the drug actinomycin D. The 9.1-kb species appears to be slightly larger than the genomic RNA. If the linear double-stranded 9.1-kb species is treated with Escherichia coli exonuclease III and allowed to anneal, circular DNA molecules can be observed. Furthermore, polyadenylate-containing short genomic RNA fragments (0.5 to 1.0 kb) can anneal to both the 5' and the 3' termini of 9.1-kb complementary DNA. The polyadenylate moiety of the RNA fragments can be identified by tagging it with circular polyoma DNA containing polydeoxybromouridylic acid tails. Thus, the 9.1-kb complementary DNA transcript with two circular polyoma DNA molecules at its termini can be observed. However, when similar annealings are performed with 8.5-kb complementary DNA species, only one end of the resulting molecule has circular polyoma DNA. We conclude that the 9.1-kb complementary DNA species has a large terminal redundancy. The sequences involved in terminal redundancy appear to be derived from the 3' end of the genomic RNA.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6245245      PMCID: PMC288563     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Avian myeloblastosis virus RNA is terminally redundant: implications for the mechanism of retrovirus replication.

Authors:  E Stoll; M A Billeter; A Palmenberg; C Weissmann
Journal:  Cell       Date:  1977-09       Impact factor: 41.582

2.  Kinetics of synthesis, structure and purification of avian sarcoma virus-specific DNA made in the cytoplasm of acutely infected cells.

Authors:  H E Varmus; S Heasley; H J Kung; H Oppermann; V C Smith; J M Bishop; P R Shank
Journal:  J Mol Biol       Date:  1978-03-25       Impact factor: 5.469

3.  Purification of the RNA-directed DNA polymerase from avian myeloblastosis virus and its assay with polynucleotide templates.

Authors:  I M Verma; D Baltimore
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

4.  RNA metabolism of murine leukemia virus: size analysis of nuclear pulse-labeled virus-specific RNA.

Authors:  H Fan
Journal:  Cell       Date:  1977-06       Impact factor: 41.582

5.  Rous sarcoma virus genome is terminally redundant: the 5' sequence.

Authors:  W A Haseltine; A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

6.  Rous sarcoma virus genome is terminally redundant: the 3' sequence.

Authors:  D E Schwartz; P C Zamecnik; H L Weith
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

7.  Nucleotide sequence at the 5' terminus of the avian sarcoma virus genome.

Authors:  J Shine; A P Czernilofsky; R Friedrich; J M Bishop; H M Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

8.  In vitro synthesis of infectious DNA of murine leukaemia virus.

Authors:  E Rothenberg; D Smotkin; D Baltimore; R A Weinberg
Journal:  Nature       Date:  1977-09-08       Impact factor: 49.962

9.  Synthesis of long, representative DNA copies of the murine RNA tumor virus genome.

Authors:  E Rothenberg; D Baltimore
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

10.  Increased length of DNA made by virions of murine leukemia virus at limiting magnesium ion concentration.

Authors:  E Rothenberg; D Baltimore
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

View more
  8 in total

1.  Efficient initiation and strand transfer of polypurine tract-primed plus-strand DNA prevent strand transfer of internally initiated plus-strand DNA.

Authors:  E H Bowman; V K Pathak; W S Hu
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

2.  Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. I. Kinetics of synthesis and size of minus- and plus-strand transcripts.

Authors:  L R Boone; A M Skalka
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

3.  Synthesis of murine leukemia viral DNA in vitro: evidence for plus-strand DNA synthesis at both ends of the genome.

Authors:  L DesGroseillers; E Rassart; M Zollinger; P Jolicoeur
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

4.  Long terminal repeat of murine retroviral DNAs: sequence analysis, host-proviral junctions, and preintegration site.

Authors:  C Van Beveren; E Rands; S K Chattopadhyay; D R Lowy; I M Verma
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

5.  Molecular cloning of unintegrated Moloney mouse sarcoma virus DNA in bacteriophage lambda.

Authors:  I M Verma; M H Lai; R A Bosselman; M A McKennett; H Fan; A Berns
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

6.  Equine infectious anemia virus and human immunodeficiency virus DNA synthesis in vitro: characterization of the endogenous reverse transcriptase reaction.

Authors:  K Borroto-Esoda; L R Boone
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

7.  Structure of Moloney murine leukemia viral DNA: nucleotide sequence of the 5' long terminal repeat and adjacent cellular sequences.

Authors:  C Van Beveren; J G Goddard; A Berns; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

8.  Evidence from cauliflower mosaic virus virion DNA for additional discontinuities in the plus strand.

Authors:  A J Maule; C M Thomas
Journal:  Nucleic Acids Res       Date:  1985-10-25       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.